Not applicableStudy completedNCT04451980What this trial is testingThe HIV, Adipose Tissue Immunology, and Metabolism StudyWho this might be right forHivDiabetes Mellitus, Type 2 Vanderbilt University Medical Center 172
Testing effectiveness (Phase 2)Looking for participantsNCT07221123What this trial is testingBoosting Olfactory and Sensory Training Study (BOOST)Who this might be right forHIV (Human Immunodeficiency Virus) University of Alabama at Birmingham 80
Not applicableActive Not RecruitingNCT05026723What this trial is testingFood as Medicine for HIV and DiabetesWho this might be right forDiabetes Mellitus, Type 2HIV InfectionsPreDiabetes University of North Carolina, Chapel Hill 200
Post-approval studies (Phase 4)Study completedNCT00853840What this trial is testingStudy To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving MaravirocWho this might be right forAIDS ViiV Healthcare 18
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT01490671What this trial is testingEvaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02304185What this trial is testingSafety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult VolunteersWho this might be right forHealthy Crucell Holland BV 50
Testing effectiveness (Phase 2)Study completedNCT01174914What this trial is testingEffectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+Who this might be right forHIV Seropositivity The Ojai Foundation 171
Early research (Phase 1)Study completedNCT03441984What this trial is testingTo Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy VolunteersWho this might be right forHIV Infections ViiV Healthcare 36
Early research (Phase 1)Study completedNCT01423825What this trial is testingEvaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableLooking for participantsNCT05881447What this trial is testingPrevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaWho this might be right forChronic Kidney DiseasesType 2 Diabetes MellitusArterial Hypertension+8 more Swiss Tropical & Public Health Institute 1,200
Large-scale testing (Phase 3)Study completedNCT00547898What this trial is testingSafety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaWho this might be right forHIV Associated Diarrhea Bausch Health Americas, Inc. 374
Early research (Phase 1)Study completedNCT00000652What this trial is testingA Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV InfectionWho this might be right forHIV Infections National Cancer Institute (NCI) 85
Early research (Phase 1)Study completedNCT00821535What this trial is testingInvestigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese VolunteersWho this might be right forHuman Immunodeficiency Virus (HIV) Infection ViiV Healthcare 12
Testing effectiveness (Phase 2)Study completedNCT00006211What this trial is testingCapravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV TreatmentsWho this might be right forHIV Infections Agouron Pharmaceuticals 350
Not applicableStudy completedNCT00872872What this trial is testingNevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)Who this might be right forNVP Plasma LevelNVP Related Mutation3TC Related Mutation Thai Red Cross AIDS Research Centre 30
Testing effectiveness (Phase 2)Study completedNCT01687218What this trial is testingSafety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% GelWho this might be right forHIV CONRAD 195
Large-scale testing (Phase 3)Study completedNCT00608023What this trial is testingTH9507 Extension Study in Patients With HIV-Associated LipodystrophyWho this might be right forLipodystrophyHIV Infections Theratechnologies 263
Early research (Phase 1)Study completedNCT01386489What this trial is testingImmune Responses to Two Experimental HIV Vaccines in Healthy AdultsWho this might be right forHIV NegativeAdaptive ImmunityInnate Immunity National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT00002274What this trial is testingDdI in Patients With AIDS Who Become Sicker While Taking ZidovudineWho this might be right forHIV InfectionsLeukoencephalopathy, Progressive Multifocal Bristol-Myers Squibb